193 related articles for article (PubMed ID: 35698805)
1. See-and-treat in-office hysteroscopy versus operative hysteroscopy for the treatment of retained products of conception: A retrospective study.
Raz N; Sigal E; Gonzalez Arjona F; Calidona C; Garzon S; Uccella S; Laganà AS; Haimovich S
J Obstet Gynaecol Res; 2022 Sep; 48(9):2459-2465. PubMed ID: 35698805
[TBL] [Abstract][Full Text] [Related]
2. Office Operative Hysteroscopy for the Management of Retained Products of Conception.
Mohr-Sasson A; Gur T; Meyer R; Mashiach R; Stockheim D
Reprod Sci; 2022 Mar; 29(3):761-767. PubMed ID: 35020188
[TBL] [Abstract][Full Text] [Related]
3. Two-step hysteroscopy for management of morbidly adherent retained products of conception.
Smorgick N; Rabinovitch I; Levinsohn-Tavor O; Maymon R; Vaknin Z; Pansky M
Arch Gynecol Obstet; 2019 Sep; 300(3):669-674. PubMed ID: 31321494
[TBL] [Abstract][Full Text] [Related]
4. Office hysteroscopy in removing retained products of conception - a highly successful approach with minimal complications.
Jakopič Maček K; Blaganje M; Kenda Šuster N; Drusany Starič K; Kobal B
J Obstet Gynaecol; 2020 Nov; 40(8):1122-1126. PubMed ID: 31793362
[TBL] [Abstract][Full Text] [Related]
5. Hysteroscopic morcellation vs. curettage for removal of retained products of conception: a multicenter randomized controlled trial.
Wagenaar LP; Hamerlynck TW; Radder CM; Peters LW; Weyers S; Schoot BC; van Vliet HA
Fertil Steril; 2023 Dec; 120(6):1243-1251. PubMed ID: 37657600
[TBL] [Abstract][Full Text] [Related]
6. Hysteroscopic Removal of Retained Products of Conception Implanted Over a Focal Area of Adenomyosis: A Case Report.
Alonso L; Nieto L; Carugno J
J Minim Invasive Gynecol; 2018; 25(3):382-383. PubMed ID: 28939480
[TBL] [Abstract][Full Text] [Related]
7. Operative hysteroscopy for retained products of conception: Efficacy and subsequent fertility.
Capmas P; Lobersztajn A; Duminil L; Barral T; Pourcelot AG; Fernandez H
J Gynecol Obstet Hum Reprod; 2019 Mar; 48(3):151-154. PubMed ID: 30553048
[TBL] [Abstract][Full Text] [Related]
8. Office intrauterine morcellation for retained products of conception.
Damiani GR; Di Gennaro D; Vimercati A; Cicinelli E; Perrone AM; De Iaco P; Malvasi A; Gaetani M; Cascardi E; Cazzato G; Dellino M; Pellegrino A; Vitagliano A
Minim Invasive Ther Allied Technol; 2023 Dec; 32(6):323-328. PubMed ID: 37493491
[TBL] [Abstract][Full Text] [Related]
9. Hysteroscopic management of retained products of conception: meta-analysis and literature review.
Smorgick N; Barel O; Fuchs N; Ben-Ami I; Pansky M; Vaknin Z
Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():19-22. PubMed ID: 24332096
[TBL] [Abstract][Full Text] [Related]
10. Intrauterine adhesions after hysteroscopic treatment for retained products of conception: what are the risk factors?
Barel O; Krakov A; Pansky M; Vaknin Z; Halperin R; Smorgick N
Fertil Steril; 2015 Mar; 103(3):775-9. PubMed ID: 25527235
[TBL] [Abstract][Full Text] [Related]
11. Hysteroscopic removal of retained products of conception following first trimester medical abortion.
Smorgick N; Levinsohn-Tavor O; Ben-Ami I; Maymon R; Pansky M; Vaknin Z
Gynecol Minim Invasive Ther; 2017; 6(4):183-185. PubMed ID: 30254910
[TBL] [Abstract][Full Text] [Related]
12. Hysteroscopy-assisted suction curettage for early pregnancy loss: does it reduce retained products of conception and postoperative intrauterine adhesions?
Moore O; Tzur T; Vaknin Z; Rabbi ML; Smorgick N
Arch Gynecol Obstet; 2024 Jan; 309(1):205-210. PubMed ID: 37782418
[TBL] [Abstract][Full Text] [Related]
13. Ultrasound for diagnosis of postpartum retained products of conception-How accurate we are?
Yagur Y; Jurman L; Weitzner O; Arbib N; Markovitch O; Klein Z; Daykan Y; Schonman R
BMC Pregnancy Childbirth; 2023 Aug; 23(1):572. PubMed ID: 37563560
[TBL] [Abstract][Full Text] [Related]
14. Hysteroscopic tissue removal system (MyoSure) for the resection of polyps, sub-mucosal leiomyomas and retained products of conception in an out-patient setting: A single UK institution experience.
Georgiou D; Tranoulis A; Jackson TL
Eur J Obstet Gynecol Reprod Biol; 2018 Dec; 231():147-151. PubMed ID: 30388609
[TBL] [Abstract][Full Text] [Related]
15. Operative hysteroscopy in the minimally invasive management of interstitial pregnancy and interstitially retained products of conception: A case report and systematic literature review.
D'hoore E; D'hoore L; Van den Berghe S; Roets E; van Wessel S; Hamerlynck T
Eur J Obstet Gynecol Reprod Biol; 2021 Oct; 265():54-59. PubMed ID: 34428687
[TBL] [Abstract][Full Text] [Related]
16. Does the time interval between the diagnosis to hysteroscopic evacuation of retained products of conception affect reproductive outcome?
Tarasov M; Burke YZ; Stockheim D; Orvieto R; Cohen SB
Arch Gynecol Obstet; 2020 Dec; 302(6):1523-1528. PubMed ID: 32785781
[TBL] [Abstract][Full Text] [Related]
17. Intercoat (Oxiplex/AP gel) for preventing intrauterine adhesions after operative hysteroscopy for suspected retained products of conception: double-blind, prospective, randomized pilot study.
Fuchs N; Smorgick N; Ben Ami I; Vaknin Z; Tovbin Y; Halperin R; Pansky M
J Minim Invasive Gynecol; 2014; 21(1):126-30. PubMed ID: 23954387
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of Office-based Operative Hysteroscopy by a Tissue Removal System without Anesthesia.
Mor M; Kochav MG; Ezratty J; Dovev MN; Eisenberg N; Smorgick N
J Minim Invasive Gynecol; 2024 May; ():. PubMed ID: 38740128
[TBL] [Abstract][Full Text] [Related]
19. Serum β-HCG Level in Women Diagnosed as Having Retained Products Of Conception: A Prospective Cohort Study.
Smorgick N; Segal H; Eisenberg N; Dovev MN; Dvash S; Rabinovich I
J Minim Invasive Gynecol; 2022 Mar; 29(3):424-428. PubMed ID: 34801711
[TBL] [Abstract][Full Text] [Related]
20. Postpartum retained products of conception: Is it possible to avoid postpartum curettage?
Nir A; Mor M; Yekutiel M; Eisenberg N; Smorgick N
Int J Gynaecol Obstet; 2022 Feb; 156(2):231-235. PubMed ID: 33811338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
